FDA grants priority review to Merck’s new biologics license application for V116
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
His most recent stint was with Danone India as its Managing Director
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
Receives registration of Valganciclovir powder for oral solution in Germany
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Demonstrate significant bleed reduction in hemophilia A and B
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
Subscribe To Our Newsletter & Stay Updated